BIO-key International, Inc.

NasdaqCM:BKYI Stock Report

Market Cap: US$3.2m

BIO-key International Management

Management criteria checks 4/4

BIO-key International's CEO is Mike DePasquale, appointed in Jan 2003, has a tenure of 21.92 years. total yearly compensation is $291.53K, comprised of 93% salary and 7% bonuses, including company stock and options. directly owns 1.06% of the company’s shares, worth $34.26K. The average tenure of the management team and the board of directors is 7.8 years and 7.7 years respectively.

Key information

Mike DePasquale

Chief executive officer

US$291.5k

Total compensation

CEO salary percentage93.0%
CEO tenure21.9yrs
CEO ownership1.1%
Management average tenure7.8yrs
Board average tenure7.7yrs

Recent management updates

Recent updates

BIO-key GAAP EPS of -$0.21, revenue of $1.9M

Aug 12

Here's Why Shareholders May Want To Be Cautious With Increasing BIO-key International, Inc.'s (NASDAQ:BKYI) CEO Pay Packet

Jun 12
Here's Why Shareholders May Want To Be Cautious With Increasing BIO-key International, Inc.'s (NASDAQ:BKYI) CEO Pay Packet

CEO Compensation Analysis

How has Mike DePasquale's remuneration changed compared to BIO-key International's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$5m

Jun 30 2024n/an/a

-US$6m

Mar 31 2024n/an/a

-US$7m

Dec 31 2023US$292kUS$271k

-US$9m

Sep 30 2023n/an/a

-US$13m

Jun 30 2023n/an/a

-US$14m

Mar 31 2023n/an/a

-US$13m

Dec 31 2022US$372kUS$296k

-US$12m

Sep 30 2022n/an/a

-US$7m

Jun 30 2022n/an/a

-US$6m

Mar 31 2022n/an/a

-US$5m

Dec 31 2021US$277kUS$275k

-US$5m

Sep 30 2021n/an/a

-US$4m

Jun 30 2021n/an/a

-US$7m

Mar 31 2021n/an/a

-US$7m

Dec 31 2020US$349kUS$275k

-US$10m

Sep 30 2020n/an/a

-US$18m

Jun 30 2020n/an/a

-US$16m

Mar 31 2020n/an/a

-US$16m

Dec 31 2019US$311kUS$275k

-US$15m

Sep 30 2019n/an/a

-US$6m

Jun 30 2019n/an/a

-US$8m

Mar 31 2019n/an/a

-US$8m

Dec 31 2018US$333kUS$275k

-US$8m

Sep 30 2018n/an/a

-US$7m

Jun 30 2018n/an/a

-US$6m

Mar 31 2018n/an/a

-US$6m

Dec 31 2017US$843kUS$250k

-US$5m

Compensation vs Market: Mike's total compensation ($USD291.53K) is below average for companies of similar size in the US market ($USD653.16K).

Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.

CEO

Mike DePasquale (69 yo)

21.9yrs

Tenure

US$291,527

Compensation

Mr. Michael W. DePasquale, also known as Mike, has been the Chief Executive Officer of BIO-key International Inc. since January 3, 2003. He has been the Chairman and Director of BIO-key International Inc....

Leadership Team

NamePositionTenureCompensationOwnership
Michael DePasquale
Chairman & CEO21.9yrsUS$291.53k1.06%
$ 34.3k
Cecilia Welch
Chief Financial Officer15yrsUS$207.70k0.051%
$ 1.6k
James Sullivan
Senior VP of Strategy & Compliance and Chief Legal Officer4.8yrsUS$235.41k1.2%
$ 38.8k
Mira LaCous
Chief Technology Officer10.8yrsUS$240.43k0.28%
$ 9.1k
Akintunde Jeje
Managing Director of Africa4.9yrsno datano data
Alex Rocha
Managing Director of EMEA2.6yrsno datano data
Mark Cochran
President of PortalGuardno datano datano data

7.8yrs

Average Tenure

63yo

Average Age

Experienced Management: BKYI's management team is seasoned and experienced (7.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Michael DePasquale
Chairman & CEO21.9yrsUS$291.53k1.06%
$ 34.3k
Cameron Williams
Independent Director1.5yrsUS$4.00k0.24%
$ 7.7k
Robert Michel
Independent Director7.7yrsUS$11.00k0.28%
$ 9.1k
Kwok Fong Wong
Vice-Chairman of the Board9yrsno data0.84%
$ 27.3k
Emmanuel Alia
Independent Director4.7yrsUS$10.00k0.25%
$ 8.2k

7.7yrs

Average Tenure

67yo

Average Age

Experienced Board: BKYI's board of directors are considered experienced (7.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 22:27
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BIO-key International, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jack Vander AardeMaxim Group